Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 2;24(15):12353.
doi: 10.3390/ijms241512353.

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy

Affiliations
Review

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy

Iason Psilopatis et al. Int J Mol Sci. .

Abstract

Endometrial cancer and uterine sarcoma represent the two major types of uterine cancer. In advanced stages, both cancer entities are challenging to treat and correlate with a meagre survival and prognosis. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a form of localized chemotherapy that is heated to improve the chemotherapeutic effect on peritoneal metastases. The aim of the current review is to study the role of HIPEC in the treatment of uterine cancer. A literature review was conducted using the MEDLINE and LIVIVO databases with a view to identifying relevant studies. By employing the search terms "hyperthermic intraperitoneal chemotherapy", "uterine cancer", "endometrial cancer", and/or "uterine sarcoma", we managed to identify 26 studies published between 2004 and 2023. The present work embodies the most up-to-date, comprehensive review of the literature centering on the particular role of HIPEC as treatment modality for peritoneally metastasized uterine cancer. Patients treated with cytoreductive surgery, alongside HIPEC, seem to profit from not only higher survival but also lower recurrence rates. Factors such as the completeness of cytoreductive surgery, the peritoneal cancer index, the histologic subtype, or the applied chemotherapeutic agent, all influence HIPEC therapy effectiveness. In summary, HIPEC seems to represent a promising treatment alternative for aggressive uterine cancer.

Keywords: cancer; chemotherapy; endometrial; hyperthermic; intraperitoneal; sarcoma; uterine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanism of action of HIPEC in peritoneal carcinomatosis.
Figure 2
Figure 2
PRISMA flow diagram visually summarizing the screening process.

Similar articles

Cited by

References

    1. Americal Cancer Society Key Statistics for Endometrial Cancer. [(accessed on 1 July 2023)]. Available online: https://www.cancer.org/cancer/types/endometrial-cancer/about/key-statist....
    1. National Cancer Institute Cancer Stat Facts: Uterine Cancer. [(accessed on 1 July 2023)]; Available online: https://seer.cancer.gov/statfacts/html/corp.html.
    1. Sherman M.E., Bur M.E., Kurman R.J. p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum. Pathol. 1995;26:1268–1274. doi: 10.1016/0046-8177(95)90204-X. - DOI - PubMed
    1. Takai N., Narahara H. Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer. Obstet. Gynecol. Int. 2010;2010:923824. doi: 10.1155/2010/923824. - DOI - PMC - PubMed
    1. Jiang S., Dowdy S.C., Meng X.W., Wang Z., Jones M.B., Podratz K.C., Jiang S.W. Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Gynecol. Oncol. 2007;105:493–500. doi: 10.1016/j.ygyno.2007.01.012. - DOI - PMC - PubMed

MeSH terms